EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Raloxifene Protects Oxygen-Glucose-Deprived Astrocyte Cells Used to Mimic Hypoxic-Ischemic Brain Injury

Nicolás Toro-Urrego iD, Juan P Luaces, Tamara Kobiec iD, Lucas Udovin, Sofía Bordet, Matilde Otero-Losada iD, Francisco Capani

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252212121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nicolás Toro-Urrego und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Altos Estudios en Ciencias Humanas y de la Salud, Universidad Abierta Interamericana, Consejo Nacional de Investigaciones Científicas y Téc…. Hauptthemen laut MEDLINE: Raloxifene Hydrochloride, Glucose, Astrocytes, Oxygen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Investigaciones Científicas y Técnicas. (CONICET), Universidad de Buenos Aires (UBA); Agencia Nacional de Promoción de Ciencia y Técnica (A…, Consejo Nacional de Investigaciones Científicas y Técnicas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perinatal asphyxia (PA) is a clinical condition characterized by oxygen supply suspension before, during, or immediately after birth, and it is an important risk factor for neurodevelopmental damage. Its estimated 1/1000 live births incidence in developed countries rises to 5–10-fold in developing countries. Schizophrenia, cerebral palsy, mental retardation, epilepsy, blindness, and others are among the highly disabling chronic pathologies associated with PA. However, so far, there is no effective therapy to neutralize or reduce PA-induced harm. Selective regulators of estrogen activity in tissues and selective estrogen receptor modulators like raloxifene have shown neuroprotective activity in different pathological scenarios. Their effect on PA is yet unknown. The purpose of this paper is to examine whether raloxifene showed neuroprotection in an oxygen–glucose deprivation/reoxygenation astrocyte cell model. To study this issue, T98G cells in culture were treated with a glucose-free DMEM medium and incubated at 37 °C in a hypoxia chamber with 1% O2 for 3, 6, 12, and 24 h. Cultures were supplemented with raloxifene 10, and 100 nM during both glucose and oxygen deprivation and reoxygenation periods. Raloxifene 100 nM and 10 nM improved cell survival—65.34% and 70.56%, respectively, compared with the control cell groups. Mitochondrial membrane potential was preserved by 58.9% 10 nM raloxifene and 81.57% 100 nM raloxifene cotreatment. Raloxifene co-treatment reduced superoxide production by 72.72% and peroxide production by 57%. Mitochondrial mass was preserved by 47.4%, 75.5%, and 89% in T98G cells exposed to 6-h oxygen–glucose deprivation followed by 3, 6, and 9 h of reoxygenation, respectively. Therefore, raloxifene improved cell survival and mitochondrial membrane potential and reduced lipid peroxidation and reactive oxygen species (ROS) production, suggesting a direct effect on mitochondria. In this study, raloxifene protected oxygen–glucose-deprived astrocyte cells, used to mimic hypoxic–ischemic brain injury. Two examiners performed the qualitative assessment in a double-blind fashion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Raloxifene HydrochlorideGlucoseAstrocytesOxygenHypoxia-Ischemia, BrainNeuroprotective AgentsMembrane Potential, MitochondrialHumansCell SurvivalReactive Oxygen SpeciesCell HypoxiaOxidative Stress

Stichwörter der Autor:innen

astrocytesglucose deprivationhypoxic–ischemic brain injuryneuroprotectionoxygen deprivationraloxifene

Substanzen

Raloxifene HydrochlorideGlucoseOxygenNeuroprotective AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • Centro de Altos Estudios en Ciencias Humanas y de la Salud, Universidad Abierta Interamericana, Consejo Nacional de Investigaciones Científicas y Técnicas, CAECIHS, UAI-CONICET, Buenos Aires C1270AAH, Argentina.
  • Centro de Investigaciones en Psicología y Psicopedagogía (CIPP), Facultad de Psicología y Psicopedagogía, Pontificia Universidad Católica Argentina (UCA), Buenos Aires C1107AFB, Argentina.
  • Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Santiago 7500912, Chile.

ORCID-Profile: Nicolás Toro-Urrego, Tamara Kobiec, Matilde Otero-Losada

Förderung

  • Consejo Nacional de Investigaciones Científicas y Técnicas. (CONICET), Universidad de Buenos Aires (UBA); Agencia Nacional de Promoción de Ciencia y Técnica (A…
  • Consejo Nacional de Investigaciones Científicas y Técnicas

Zitieren

APA

Toro-Urrego, N., Luaces, J. P., Kobiec, T., Udovin, L., Bordet, S., Otero-Losada, M., & Capani, F. (2024). Raloxifene Protects Oxygen-Glucose-Deprived Astrocyte Cells Used to Mimic Hypoxic-Ischemic Brain Injury. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212121

Vancouver

Toro-Urrego N, Luaces JP, Kobiec T, Udovin L, Bordet S, Otero-Losada M, et al. Raloxifene Protects Oxygen-Glucose-Deprived Astrocyte Cells Used to Mimic Hypoxic-Ischemic Brain Injury. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212121

BibTeX
@article{ToroUrrego2024,
  author = {Toro-Urrego, Nicolás and Luaces, Juan P and Kobiec, Tamara and Udovin, Lucas and Bordet, Sofía and Otero-Losada, Matilde and Capani, Francisco},
  title = {Raloxifene Protects Oxygen-Glucose-Deprived Astrocyte Cells Used to Mimic Hypoxic-Ischemic Brain Injury},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252212121}
}
Kostenlos starten →